References
Ahn, I. E., T. Jerussi, M. Farooqui, X. Tian, A. Wiestner, and J. Gea-Banacloche. 2016. Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib. Blood 128(15):1940-1943.
Al-Yasiri, M. H., A. C. Normand, C. L’Ollivier, L. Lachaud, N. Bourgeois, S. Rebaudet, R. Piarroux, J. F. Mauffrey, and S. Ranque. 2016. Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls. Scientific Reports 6(1):36157.
Alexander, B. D., M. D. Johnson, C. D. Pfeiffer, C. Jimenez-Ortigosa, J. Catania, R. Booker, M. Castanheira, S. A. Messer, D. S. Perlin, and M. A. Pfaller. 2013. Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clinical Infectious Diseases 56(12):1724-1732.
Ali, M. E., M. Gunn, T. Stackhouse, S. Waliullah, B. Guo, A. Culbreath, and T. Brenneman. 2021. Sensitivity of Aspergillus flavus isolates from peanut seeds in Georgia to azoxystrobin, a quinone outside inhibitor (QoI) fungicide. Journal of Fungi (Basel) 7(4):284.
Aylor, D. 2017. Aerial dispersal of pollen and spores, Epidemiology. St. Paul, MN: The American Phytopathological Society.
Barber, A. E., J. Riedel, T. Sae-Ong, K. Kang, W. Brabetz, G. Panagiotou, H. B. Deising, and O. Kurzai. 2020. Effects of agricultural fungicide use on Aspergillus fumigatus abundance, antifungal susceptibility, and population structure. mBio 11(6):e02213-02220.
Beardsley, J., C. L. Halliday, S. C. Chen, and T. C. Sorrell. 2018. Responding to the emergence of antifungal drug resistance: Perspectives from the bench and the bedside. Future Microbiology 13(10):1175-1191.
Beer, K. D., E. C. Farnon, S. Jain, C. Jamerson, S. Lineberger, J. Miller, E. L. Berkow, S. R. Lockhart, T. Chiller, and B. R. Jackson. 2018. Multidrug-resistant Aspergillus fumigatus carrying mutations linked to environmental fungicide exposure—three states, 2010-2017. MMWR Morbidity and Mortality Weekly Report 67(38):1064-1067.
Benedict, K., B. R. Jackson, T. Chiller, and K. D. Beer. 2019. Estimation of direct healthcare costs of fungal diseases in the United States. Clinical Infectious Diseases 68(11):1791-1797.
Benedict, K., S. V. Tsay, M. G. Bartoces, S. Vallabhaneni, B. R. Jackson, and L. A. Hicks. 2022a. Outpatient antifungal prescribing patterns in the United States, 2018. Antimicrobial Stewardship & Healthcare Epidemiology 1(1):e68.
Benedict, K., H. K. Whitham, and B. R. Jackson. 2022b. Economic burden of fungal diseases in the United States. Open Forum Infectious Diseases 9(4):ofac097.
Bensasson, D., J. Dicks, J. M. Ludwig, C. J. Bond, A. Elliston, I. N. Roberts, and S. A. James. 2019. Diverse lineages of Candida albicans live on old oaks. Genetics 211(1):277-288.
Berman, J., and D. J. Krysan. 2020. Drug resistance and tolerance in fungi. Nature Reviews Microbiology 18(6):319-331.
Bhattacharya, S., B. D. Esquivel, and T. C. White. 2018. Overexpression or deletion of ergosterol biosynthesis genes alters doubling time, response to stress agents, and drug susceptibility in Saccharomyces cerevisiae. mBio 9(4):e01291-01218.
Bitar, D., O. Lortholary, Y. Le Strat, J. Nicolau, B. Coignard, P. Tattevin, D. Che, and F. Dromer. 2014. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerging Infectious Diseases 20(7):1163-1169.
Bongomin, F., S. Gago, R. O. Oladele, and D. W. Denning. 2017. Global and multi-national prevalence of fungal diseases—estimate precision. Journal of Fungi 3(4):57.
Bongomin, F., C. R. Batac, M. D. Richardson, and D. W. Denning. 2018. A review of onychomycosis due to Aspergillus species. Mycopathologia 183(3):485-493.
Brackin, A. P., J. M. G. Shelton, A. Abdolrasouli, M. C. Fisher, and T. R. Sewell. 2020. A low-cost tebuconazole-based screening test for azole-resistant Aspergillus fumigatus. Current Protocols in Microbiology 58(1):e112.
Break, T. J., V. Oikonomou, N. Dutzan, J. V. Desai, M. Swidergall, T. Freiwald, D. Chauss, O. J. Harrison, J. Alejo, D. W. Williams, S. Pittaluga, C. R. Lee, N. Bouladoux, M. Swamydas, K. W. Hoffman, T. Greenwell-Wild, V. M. Bruno, L. B. Rosen, W. Lwin, A. Renteria, S. M. Pontejo, J. P. Shannon, I. A. Myles, P. Olbrich, E. M. N. Ferre, M. Schmitt, D. Martin, Genomics and Computational Biology Care, D. L. Barber, N. V. Solis, L. D. Notarangelo, D. V. Serreze, M. Matsumoto, H. D. Hickman, P. M. Murphy, M. S. Anderson, J. K. Lim, S. M. Holland, S. G. Filler, B. Afzali, Y. Belkaid, N. M. Moutsopoulos, and M. S. Lionakis. 2021. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science 371(6526).
Brilhante, R. S. N., L. P. Alencar, S. P. Bandeira, J. A. Sales, A. J. J. Evangelista, R. Serpa, R. A. Cordeiro, W. A. Pereira-Neto, J. J. C. Sidrim, D. Castelo-Branco, and M. F. G. Rocha. 2019. Exposure of Candida parapsilosis complex to agricultural azoles: An overview of the role of environmental determinants for the development of resistance. Science of the Total Environment 650(Pt 1):1231-1238.
Brown, L., A. K. Leck, M. Gichangi, M. J. Burton, and D. W. Denning. 2021. The global incidence and diagnosis of fungal keratitis. Lancet Infectious Diseases 21(3):e49-e57.
Bueid, A., S. J. Howard, C. B. Moore, M. D. Richardson, E. Harrison, P. Bowyer, and D. W. Denning. 2010. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. Journal of Antimicrobial Chemotherapy 65(10):2116-2118.
Buil, J. B., E. Snelders, L. B. Denardi, W. J. G. Melchers, and P. E. Verweij. 2019. Trends in azole resistance in Aspergillus fumigatus, the Netherlands, 1994-2016. Emerging Infectious Diseases 25(1):176-178.
Buil, J. B., H. A. L. van der Lee, A. Rijs, J. Zoll, J. Hovestadt, W. J. G. Melchers, and P. E. Verweij. 2017. Single-center evaluation of an agar-based screening for azole resistance in Aspergillus fumigatus by using VIPcheck. Antimicrobial Agents and Chemotherapy 61(12):e01250-01217.
Burks, C., A. Darby, L. Gomez Londono, M. Momany, and M. T. Brewer. 2021. Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance. PLoS Pathogens 17(7):e1009711.
Bustamante, B., L. R. Illescas, A. Posadas, and P. E. Campos. 2020. Azole resistance among clinical isolates of Aspergillus fumigatus in Lima, Peru. Medical Mycology 58(1):54-60.
Carr, A., and J. Stringer. 2019. Achaogen, Inc. (AKAO). Needham & Company, LLC. https://needham.bluematrix.com/docs/html/e821e131-b928-4b4d-86dd-63ec995e6e21.html (accessed February 24, 2023).
Casadevall, A. 2020. Climate change brings the specter of new infectious diseases. Journal of Clinical Investigations 130(2):553-555.
Casadevall, A., D. P. Kontoyiannis, and V. Robert. 2019. On the emergence of Candida auris: Climate change, azoles, swamps, and birds. mBio 10(4).
CDC (Centers for Disease Control and Prevention). 2019. Antibiotic resistance threats in the United States: 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC.
CDC. 2020. Antifungal susceptibility testing and interpretation. https://www.cdc.gov/fungal/candida-auris/c-auris-antifungal.html (accessed October 5, 2022).
CDC. 2021a. Antifungal-resistant Aspergillus. https://www.cdc.gov/fungal/diseases/aspergillosis/antifungal-resistant.html (accessed August 31, 2022).
CDC. 2021b. Antifungal resistance: People and environment. https://www.cdc.gov/fungal/diseases/aspergillosis/azole-resistant-aspergillus.html (accessed August 22, 2022).
CDC. 2021c. Healthcare-associated infections—Community interface. https://www.cdc.gov/hai/eip/haicviz.html (accessed July 29, 2022).
Chen, Y., F. Dong, J. Zhao, H. Fan, C. Qin, R. Li, P. E. Verweij, Y. Zheng, and L. Han. 2020. High azole resistance in Aspergillus fumigatus isolates from strawberry fields, China, 2018. Emerging Infectious Diseases 26(1):81-89.
Chong, G. L., W. W. van de Sande, G. J. Dingemans, G. R. Gaajetaan, A. G. Vonk, M. P. Hayette, D. W. van Tegelen, G. F. Simons, and B. J. Rijnders. 2015. Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid. Journal of Clinical Microbiology 53(3):868-874.
Chow, N. A., L. Gade, S. V. Tsay, K. Forsberg, J. A. Greenko, K. L. Southwick, P. M. Barrett, J. L. Kerins, S. R. Lockhart, T. M. Chiller, A. P. Litvintseva, and U.S. Candida auris Investigation Team. 2018. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: A molecular epidemiological survey. Lancet Infectious Diseases 18(12):1377-1384.
Collar, A. L., M. Swamydas, M. O’Hayre, M. S. Sajib, K. W. Hoffman, S. P. Singh, A. Mourad, M. D. Johnson, E. M. Ferre, J. M. Farber, J. K. Lim, C. M. Mikelis, J. S. Gutkind, and M. S. Lionakis. 2018. The homozygous CX3CR1-M280 mutation impairs human monocyte survival. JCI Insight 3(3).
Culbreath, A. K., T. B. Brenneman, R. C. Kemerait, K. L. Stevenson, and D. J. Anco. 2019. Combinations of elemental sulfur with demethylation inhibitor fungicides for management of late leaf spot (Nothopassalora personata) of peanut. Crop Protection 125:104911.
Cunningham, A. 2021. A deadly fungus behind hospital outbreaks was found in nature for the first time. ScienceNews, April 10.
Denning, D. W. 1996. Therapeutic outcome in invasive aspergillosis. Clinical Infectious Diseases 23(3):608-615.
Doughty, K. J., H. Sierotzki, M. Semar, and A. Goertz. 2021. Selection and amplification of fungicide resistance in Aspergillus fumigatus in relation to DMI fungicide use in agronomic settings: Hotspots versus coldspots. Microorganisms 9(12).
Drakeman, D. L. 2014. Benchmarking biotech and pharmaceutical product development. Nature Biotechnology 32(7):621-625.
Drummond, R. A., M. Swamydas, V. Oikonomou, B. Zhai, I. M. Dambuza, B. C. Schaefer, A. C. Bohrer, K. D. Mayer-Barber, S. A. Lira, Y. Iwakura, S. G. Filler, G. D. Brown, B. Hube, J. R. Naglik, T. M. Hohl, and M. S. Lionakis. 2019. CARD9(+) microglia promote antifungal immunity via IL-1beta- and CXCL1-mediated neutrophil recruitment. Nature Immunology 20(5):559-570.
Drummond, R. A., J. V. Desai, E. E. Ricotta, M. Swamydas, C. Deming, S. Conlan, M. Quinones, V. Matei-Rascu, L. Sherif, D. Lecky, C. R. Lee, N. M. Green, N. Collins, A. M. Zelazny, D. R. Prevots, D. Bending, D. Withers, Y. Belkaid, J. A. Segre, and M. S. Lionakis. 2022. Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria. Cell Host and Microbe 30(7):1020-1033 e1026.
Duong, T. M. N., P. T. Nguyen, T. V. Le, H. L. P. Nguyen, B. N. T. Nguyen, B. P. T. Nguyen, T. A. Nguyen, S. C. Chen, V. R. Barrs, C. L. Halliday, T. C. Sorrell, J. N. Day, and J. Beardsley. 2020. Drug-resistant Aspergillus flavus is highly prevalent in the environment of Vietnam: A new challenge for the management of aspergillosis? Journal of Fungi (Basel) 6(4).
Duong, T. N., T. V. Le, K. H. Tran, P. T. Nguyen, B. T. Nguyen, T. A. Nguyen, H. P. Nguyen, B. T. Nguyen, M. C. Fisher, J. Rhodes, G. Marks, G. J. Fox, S. C. Chen, M. G. Walsh, V. R. Barrs, J. Talbot, C. L. Halliday, T. C. Sorrell, J. N. Day, and J. Beardsley. 2021. Azole-resistant Aspergillus fumigatus is highly prevalent in the environment of Vietnam, with marked variability by land use type. Environmental Microbiology 23(12):7632-7642.
Edwards, S. G., and N. P. Godley. 2010. Reduction of Fusarium head blight and deoxynivalenol in wheat with early fungicide applications of prothioconazole. Food Additives & Contaminants: Part A 27(5):629-635.
EPA (Environmental Protection Agency). 2022. EPA proposes registration of the new fungicide ipflufenoquin. https://www.epa.gov/pesticides/epa-proposes-registration-new-fungicide-ipflufenoquin (accessed August 1, 2022).
Etienne, K. A., E. L. Berkow, L. Gade, N. Nunnally, S. R. Lockhart, K. Beer, I. K. Jordan, L. Rishishwar, and A. P. Litvintseva. 2021. Genomic diversity of azole-resistant Aspergillus fumigatus in the United States. mBio 12(4):e0180321.
Fan, X., M. Xiao, K. Liao, T. Kudinha, H. Wang, L. Zhang, X. Hou, F. Kong, and Y. C. Xu. 2017. Notable increasing trend in azole non-susceptible Candida tropicalis causing invasive candidiasis in China (August 2009 to July 2014): Molecular epidemiology and clinical azole consumption. Frontiers in Microbiology 8:464.
FAO (Food and Agriculture Organization). 2016. The FAO action plan on antimicrobial resistance, 2016–2020. https://www.fao.org/3/i5996e/i5996e.pdf (accessed August 31, 2022).
FAO. 2021a. Climate change fans spread of pests and threatens plants and crops, new FAO study. https://www.fao.org/news/story/en/item/1402920/icode (accessed August 31, 2022).
FAO. 2021b. Strategic framework: 2022-31. Rome: Food and Agriculture Organization of the United Nations.
FAO and WHO (World Health Organization). 2021. Guidelines on integrated monitoring and surveillance of foodborne antimicrobial resistance. https://www.fao.org/fao-who-codexalimentarius/sh-proxy/en/?lnk=1&url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCXG%2B94-2021%252FCXG_94e.pdf (accessed August 23, 2022).
FAO and WHO. 2022. Foodborne antimicrobial resistance: Compendium of codex standards. Rome: FAO; WHO.
Faria-Ramos, I., S. Farinha, J. Neves-Maia, P. R. Tavares, I. M. Miranda, L. M. Estevinho, C. Pina-Vaz, and A. G. Rodrigues. 2014. Development of cross-resistance by Aspergillus fumigatus to clinical azoles following exposure to prochloraz, an agricultural azole. BMC Microbiology 14:155.
FDA (U.S. Food and Drug Administration). 2018. FDA approves fostamatinib tablets for ITP. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approvesfostamatinib-tablets-itp.
Fei, Z., A. G. Olenskyj, B. N. Bailey, and M. Earles. 2021. Enlisting 3D crop models and GANs for more data efficient and generalizable fruit detection. Paper read at Proceedings of the IEEE/CVF International Conference on Computer Vision.
Fernández-Ortuño, D., J. A. Torés, A. De Vicente, and A. Pérez-García. 2010. The QoI fungicides, the rise and fall of a successful class of agricultural fungicide. In Fungicides, O. Carisse (ed.), Croatia: IntechOpen. Pp 203-220.
Fisher, M. C., N. J. Hawkins, D. Sanglard, and S. J. Gurr. 2018. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 360(6390):739-742.
Fisher, M. C., A. Alastruey-Izquierdo, J. Berman, T. Bicanic, E. M. Bignell, P. Bowyer, M. Bromley, R. Bruggemann, G. Garber, O. A. Cornely, S. J. Gurr, T. S. Harrison, E. Kuijper, J. Rhodes, D. C. Sheppard, A. Warris, P. L. White, J. Xu, B. Zwaan, and P. E. Verweij. 2022. Tackling the emerging threat of antifungal resistance to human health. Nature Reviews Microbiology 20(9):557-571.
Fraaije, B., S. Atkins, S. Hanley, A. Macdonald, and J. Lucas. 2020. The multi-fungicide resistance status of Aspergillus fumigatus populations in arable soils and the wider European environment. Frontiers in Microbiology 11:599233.
Fuhren, J., W. S. Voskuil, C. H. Boel, P. J. Haas, F. Hagen, J. F. Meis, and J. G. Kusters. 2015. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients. Journal of Antimicrobial Chemotherapy 70(10):2894-2898.
Fuller, K. B., J. M. Alston, and O. S. Sambucci. 2014. The value of powdery mildew resistance in grapes: Evidence from California. Wine Economics and Policy 3(2):90-107.
Fungicide Resistance Action Committee. 2022. FRAC code list 2022: Fungal control agents sorted by cross-resistance pattern and mode of action. https://www.frac.info/docs/defaultsource/publications/frac-code-list/frac-code-list-2022--final.pdf?sfvrsn=b6024e9a_2 (accessed August 1, 2022).
Gabaldón, T., and L. Carreté. 2016. The birth of a deadly yeast: Tracing the evolutionary emergence of virulence traits in Candida glabrata. FEMS Yeast Research 16(2):fov110.
Garcia-Rubio, R., M. Cuenca-Estrella, and E. Mellado. 2017. Triazole resistance in Aspergillus species: An emerging problem. Drugs 77(6):599-613.
Garrett, K. A. 2021. Impact network analysis and the INA R package: Decision support for regional management interventions. Methods in Ecology and Evolution 12(9):1634-1647.
Gianessi, L., and N. Reigner. 2006. The importance of fungicides in US crop production. Outlooks on Pest Management 17(5):209.
Global Action for Fungal Infections (GAFFI). 2022. Policy brief: Chronic pulmonary aspergillosis: Global misdiagnosis of TB-like fungal lung disease. GAFFI.
Golan, J. J., and A. Pringle. 2017. Long-distance dispersal of fungi. Microbiology Spectrum 5(4):5.4.03.
Gold, J. A. W., E. E. Seagle, J. Nadle, D. M. Barter, C. A. Czaja, H. Johnston, M. M. Farley, S. Thomas, L. H. Harrison, J. Fischer, B. Pattee, R. K. Mody, E. C. Phipps, S. S. Davis, B. L. Tesini, A. Y. Zhang, T. M. Markus, W. Schaffner, S. R. Lockhart, S. Vallabhaneni, B. R. Jackson, and M. Lyman. 2021. Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017-2018. Clinical Infectious Diseases 73(9):1609-1616.
Goncalves, P., A. Melo, M. Dias, B. Almeida, L. A. Caetano, C. Verissimo, C. Viegas, and R. Sabino. 2020. Azole-resistant Aspergillus fumigatus harboring the TR34/L98H mutation: First report in Portugal in environmental samples. Microorganisms 9(1).
Govender, N. P., J. Patel, R. E. Magobo, S. Naicker, J. Wadula, A. Whitelaw, Y. Coovadia, R. Kularatne, C. Govind, S. R. Lockhart, I. L. Zietsman, and TRAC-South Africa Group. 2016. Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: Results from laboratory-based sentinel surveillance in South Africa. Journal of Antimicrobial Chemotherapy 71(7):1994-2004.
Gsaller, F., P. Hortschansky, T. Furukawa, P. D. Carr, B. Rash, J. Capilla, C. Muller, F. Bracher, P. Bowyer, H. Haas, A. A. Brakhage, and M. J. Bromley. 2016. Sterol biosynthesis and azole tolerance is governed by the opposing actions of SrbA and the CCAAT binding complex. PLoS Pathogens 12(7):e1005775.
Guinea, J., P. E. Verweij, J. Meletiadis, J. W. Mouton, F. Barchiesi, M. C. Arendrup, and Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). 2019. How to: EUCAST recommendations on the screening procedure e.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates. Clinical Microbiology and Infection 25(6):681-687.
Hagan, A. 2018. Invasive fungal infections: A creeping public health threat. https://asm.org/Articles/2018/September/Invasive-Fungal-Infections-A-Creeping-Public-Healt (accessed July 26, 2022).
Hammond, E. E., C. S. McDonald, J. Vestbo, and D. W. Denning. 2020. The global impact of Aspergillus infection on COPD. BMC Pulmonary Medicine 20(1):241.
Herbrecht, R., P. Bories, J. C. Moulin, M. P. Ledoux, and V. Letscher-Bru. 2012. Risk stratification for invasive aspergillosis in immunocompromised patients. Annals of the New York Academy of Sciences 1272:23-30.
Hernandez Nopsa, J. F., G. J. Daglish, D. W. Hagstrum, J. F. Leslie, T. W. Phillips, C. Scoglio, S. Thomas-Sharma, G. H. Walter, and K. A. Garrett. 2015. Ecological networks in stored grain: Key postharvest nodes for emerging pests, pathogens, and mycotoxins. Bioscience 65(10):985-1002.
Hevey, M. A., I. A. George, K. Raval, W. G. Powderly, and A. Spec. 2019. Presentation and mortality of cryptococcal infection varies by predisposing illness: A retrospective cohort study. American Journal of Medicine 132(8):977-983 e971.
HHS (U.S. Department of Health and Human Services). 2021. Presidential Advisory Council on Combatting Antibiotic-Resistant Bacteria. https://www.hhs.gov/ash/advisory-committees/paccarb/meetings/past-meetings/index.html (accessed August 31, 2022).
Howard, S. J., D. Cerar, M. J. Anderson, A. Albarrag, M. C. Fisher, A. C. Pasqualotto, M. Laverdiere, M. C. Arendrup, D. S. Perlin, and D. W. Denning. 2009. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerging Infectious Diseases 15(7):1068-1076.
Hurst, S. F., E. L. Berkow, K. L. Stevenson, A. P. Litvintseva, and S. R. Lockhart. 2017. Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA. Journal of Antimicrobial Chemotherapy 72(9):2443-2446.
International Chronic Granulomatous Disease Cooperative Study Group. 1991. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. New England Journal of Medicine 324(8):509-516.
Jackson, B. R., N. Chow, K. Forsberg, A. P. Litvintseva, S. R. Lockhart, R. Welsh, S. Vallabhaneni, and T. Chiller. 2019. On the origins of a species: What might explain the rise of Candida auris? Journal of Fungi (Basel) 5(3).
Kang, S. E., L. G. Sumabat, T. Melie, B. Mangum, M. Momany, and M. T. Brewer. 2020. Evidence for the agricultural origin of antimicrobial resistance in a fungal pathogen of humans. bioRxiv:2020.2005.2024.113787.
Kang, S. E., L. G. Sumabat, T. Melie, B. Mangum, M. Momany, and M. T. Brewer. 2022. Evidence for the agricultural origin of resistance to multiple antimicrobials in Aspergillus fumigatus, a fungal pathogen of humans. G3 (Bethesda) 12(2).
Kelly, S. L., and D. E. Kelly. 2013. Microbial cytochromes P450: Biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us? Philosophical Transactions of the Royal Society B: Biological Sciences 368(1612):20120476.
Kumar, V., S. C. Cheng, M. D. Johnson, S. P. Smeekens, A. Wojtowicz, E. Giamarellos-Bourboulis, J. Karjalainen, L. Franke, S. Withoff, T. S. Plantinga, F. L. van de Veerdonk, J. W. M. van der Meer, L. A. B. Joosten, P. Y. Bochud, O. Marchetti, J. R. Perfect, R. Xavier, B. J. Kullberg, C. Wijmenga, and M. G. Netea. 2014. Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia. Nature Communications 5:4675.
Lass-Florl, C., G. M. Salzer, T. Schmid, W. Rabl, H. Ulmer, and M. P. Dierichi. 1999. Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients. British Journal of Haematology 104(4):745-747.
Latgé, J. P. 1999. Aspergillus fumigatus and aspergillosis. Clinical Microbiology Reviews 12(2):310-350.
Lestrade, P. P., R. G. Bentvelsen, A. Schauwvlieghe, S. Schalekamp, W. van der Velden, E. J. Kuiper, J. van Paassen, B. van der Hoven, H. A. van der Lee, W. J. G. Melchers, A. F. de Haan, H. L. van der Hoeven, B. J. A. Rijnders, M. T. van der Beek, and P. E. Verweij. 2019a. Voriconazole resistance and mortality in invasive aspergillosis: A multicenter retrospective cohort study. Clinical Infectious Diseases 68(9):1463-1471.
Lestrade, P. P. A., J. F. Meis, W. J. G. Melchers, and P. E. Verweij. 2019b. Triazole resistance in Aspergillus fumigatus: Recent insights and challenges for patient management. Clinical Microbiology and Infection 25(7):799-806.
Lionakis, M. S., B. G. Fischer, J. K. Lim, M. Swamydas, W. Wan, C. C. Richard Lee, J. I. Cohen, P. Scheinberg, J. L. Gao, and P. M. Murphy. 2012. Chemokine receptor CCR1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis. PLoS Pathology 8(8):e1002865.
Lionakis, M. S., N. D. Albert, M. Swamydas, C. R. Lee, P. Loetscher, and D. P. Kontoyiannis. 2017a. Pharmacological blockade of the chemokine receptor CCR1 protects mice from systemic candidiasis of hematogenous origin. Antimicrobial Agents and Chemotherapy 61(3).
Lionakis, M. S., K. Dunleavy, M. Roschewski, B. C. Widemann, J. A. Butman, R. Schmitz, Y. Yang, D. E. Cole, C. Melani, C. S. Higham, J. V. Desai, M. Ceribelli, L. Chen, C. J. Thomas, R. F. Little, J. Gea-Banacloche, S. Bhaumik, M. Stetler-Stevenson, S. Pittaluga, E. S. Jaffe, J. Heiss, N. Lucas, S. M. Steinberg, L. M. Staudt, and W. H. Wilson. 2017b. Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma. Cancer Cell 31(6):833-843 e835.
Lyman, M., K. Forsberg, J. Reuben, T. Dang, R. Free, E. E. Seagle, D. J. Sexton, E. Soda, H. Jones, D. Hawkins, A. Anderson, J. Bassett, S. R. Lockhart, E. Merengwa, P. Iyengar, B. R. Jackson, and T. Chiller. 2021. Notes from the field: Transmission of pan-resistant and echinocandin-resistant Candida auris in health care facilities—Texas and the District of Columbia, January-April 2021. Morbidity and Mortality Weekly Report 70(29):1022-1023.
Magill, S. S., E. O’Leary, S. J. Janelle, D. L. Thompson, G. Dumyati, J. Nadle, L. E. Wilson, M. A. Kainer, R. Lynfield, S. Greissman, S. M. Ray, Z. Beldavs, C. Gross, W. Bamberg, M. Sievers, C. Concannon, N. Buhr, L. Warnke, M. Maloney, V. Ocampo, J. Brooks, T. Oyewumi, S. Sharmin, K. Richards, J. Rainbow, M. Samper, E. B. Hancock, D. Leaptrot, E. Scalise, F. Badrun, R. Phelps, J. R. Edwards, and Emerging Infections Program Hospital Prevalence Survey Team. 2018. Changes in prevalence of health care-associated infections in U.S. hospitals. New England Journal of Medicine 379(18):1732-1744.
Mahaffee, W. F., F. Margairaz, L. D. Ulmer, B. N. Bailey, and R. Stoll. 2023. Catching spores: Linking epidemiology, pathogen biology, and physics to ground-based airborne inoculum monitoring. Plant Disease 107(1):13-33.
Mazi, P. B., M. A. Olsen, D. Stwalley, A. M. Rauseo, C. Ayres, W. G. Powderly, and A. Spec. 2022. Attributable mortality of Candida bloodstream infections in the modern era: A propensity score analysis. Clinical Infectious Diseases 75(6):1031-1036.
Messina, J. A., E. K. Maziarz, A. Spec, D. P. Kontoyiannis, and J. R. Perfect. 2017. Disseminated cryptococcosis with brain involvement in patients with chronic lymphoid malignancies on ibrutinib. Open Forum Infectious Diseases 4(1):ofw261.
Miles, T. D., T. M. Neill, M. Colle, B. Warneke, G. Robinson, I. Stergiopoulos, and W. F. Mahaffee. 2021. Allele-specific detection methods for QoI fungicide-resistant Erysiphe necator in vineyards. Plant Disease 105(1):175-182.
Mullick, A., M. Elias, S. Picard, L. Bourget, O. Jovcevski, S. Gauthier, A. Tuite, P. Harakidas, C. Bihun, B. Massie, and P. Gros. 2004. Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infection and Immunity 72(10):5868-5876.
Nett, J. E., and D. R. Andes. 2016. Antifungal agents: Spectrum of activity, pharmacology, and clinical indications. Infectious Disease Clinics of North America 30(1):51-83.
Nguyen, N. T. B., H. Le Ngoc, N. V. Nguyen, L. V. Dinh, H. V. Nguyen, H. T. Nguyen, and D. W. Denning. 2021. Chronic pulmonary aspergillosis situation among post tuberculosis patients in Vietnam: An observational study. Journal of Fungi (Basel) 7(7).
NHS (National Health Service) England. 2022. NHS lands breakthrough in global battle against superbugs. June 15. https://www.england.nhs.uk/2022/06/nhs-lands-breakthrough-in-global-battle-against-superbugs (accessed April 26, 2023).
NICE (National Institute for Health Care Excellence). 2022. NICE reaches important milestone in the UK’s efforts to tackle antimicrobial resistance. April 12. https://www.nice.org.uk/news/article/nice-reaches-important-milestone-in-the-uk-s-efforts-to-tackle-antimicrobial-resistance (accessed April 26, 2023).
NIH (National Institutes of Health). 2018. A study to evaluate the efficacy and safety of oral VT-1161 in patients with moderate - severe interdigital tinea pedis. https://clinicaltrials.gov/ct2/show/NCT01891305?term=NCT01891305&draw=2&rank=1 (accessed August 27, 2022).
NIH. 2020. A study to evaluate the efficacy and safety of oral VT-1161 in patients with onychomycosis of the toenail. https://clinicaltrials.gov/ct2/show/NCT02267356?term=NCT02267356&draw=2&rank=1 (accessed August 27, 2022).
NIH. 2021a. A study of oral oteseconazole (VT-1161) for the treatment of patients with recurrent vaginal candidiasis (yeast infection). https://clinicaltrials.gov/ct2/show/NCT03561701?term=NCT03561701&draw=2&rank=1 (accessed August 27, 2022).
NIH. 2021b. An efficacy and safety study of APX001 in non-neutropenic patients with candidemia. https://clinicaltrials.gov/ct2/show/NCT03604705?term=NCT03604705&draw=2&rank=1 (accessed August 27, 2022).
NIH. 2022a. An open-label study of APX001 for treatment of patients with candidemia/invasive candidiasis caused by Candida auris. https://clinicaltrials.gov/ct2/show/NCT04148287?term=NCT04148287&draw=2&rank=1 (accessed August 27, 2022).
NIH. 2022b. Open-label study of APX001 for treatment of patients with invasive mold infections caused by Aspergillus or rare molds. https://clinicaltrials.gov/ct2/show/NCT04240886?term=NCT04240886&draw=2&rank=1 (accessed August 27, 2022).
NIH. 2022c. Evaluate F901318 treatment of invasive fungal infections in patients lacking treatment options. https://clinicaltrials.gov/ct2/show/NCT03583164?term=NCT+03583164&draw=2&rank=1 (accessed August 27, 2022).
NIH. 2022d. Olorofim Aspergillus infectionstudy. https://clinicaltrials.gov/ct2/show/NCT05101187?term=NCT05101187&draw=2&rank=1 (accessed August 27, 2022).
OECD (Organisation for Economic Co-operation and Development). 2018a. Guidance document for the assessment of the equivalence of technical grade active ingredients for identical microbial strains and isolates, Series on pesticides and biocides, no. 96. Paris: OECD Publishing. https://doi.org/10.1787/489def79-en.
OECD. 2018b. Working document on the risk assessment of secondary metabolites of microbial biocontrol agents, OECD environment, health and safety publications series on pesticides, no. 98. Paris: OECD Publishing. https://one.oecd.org/document/env/jm/mono(2018)33/en/pdf (accessed April 26, 2023).
OECD. 2019. Customisation opportunities of IUCLID for the management of chemical data, OECD series on testing and assessment, no. 297. Paris: OECD Publishing.
Oerke, E.-C., A.-K. Mahlein, and U. Steiner. 2014. Proximal sensing of plant diseases. In Detection and diagnostics of plant pathogens, edited by M. L. Gullino and P. J. M. Bonants. Dordrecht: Springer Netherlands. Pp. 55-68.
Oliver, J. D., G. E. M. Sibley, N. Beckmann, K. S. Dobb, M. J. Slater, L. McEntee, S. du Pre, J. Livermore, M. J. Bromley, N. P. Wiederhold, W. W. Hope, A. J. Kennedy, D. Law, and M. Birch. 2016. F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proceedings of the National Academy of Sciences of the United States of America 113(45):12809-12814.
Outterson, K. and J. Rex. 2022. UK Pull (Netflix) pilot: STEDI-based QALY value of new antibiotics implies societal value > 10m GBP/year! April 11. AMR Solutions. https://amr.solutions/2022/04/11/uk-pull-netflix-pilot-qaly-value-of-new-antibiotics-implies-societalvalue-10m-gbp-year (accessed April 26, 2023).
Pappas, P. G., C. A. Kauffman, D. R. Andes, C. J. Clancy, K. A. Marr, L. Ostrosky-Zeichner, A. C. Reboli, M. G. Schuster, J. A. Vazquez, T. J. Walsh, T. E. Zaoutis, and J. D. Sobel. 2016. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clinical Infectious Diseases 62(4):e1-e50.
Pfaller, M. A., M. Castanheira, S. R. Lockhart, A. M. Ahlquist, S. A. Messer, and R. N. Jones. 2012. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. Journal of Clinical Microbiology 50(4):1199-1203.
Pianalto, K. M., and J. A. Alspaugh. 2016. New horizons in antifungal therapy. Journal Fungi (Basel) 2(4).
Pontes, L., C. A. G. Beraquet, T. Arai, G. L. Pigolli, L. Lyra, A. Watanabe, M. L. Moretti, and A. Z. Schreiber. 2020. Aspergillus fumigatus clinical isolates carrying CYP51A with TR34/L98H/S297T/F495I substitutions detected after four-year retrospective azole resistance screening in Brazil. Antimicrobial Agents and Chemotherapy 64(3).
Price, C. L., J. E. Parker, A. G. Warrilow, D. E. Kelly, and S. L. Kelly. 2015. Azole fungicides—Understanding resistance mechanisms in agricultural fungal pathogens. Pest Management Science 71(8):1054-1058.
Pristov, K. E., and M. A. Ghannoum. 2019. Resistance of Candida to azoles and echinocandins worldwide. Clinical Microbiology and Infection 25(7):792-798.
Protsiv, M., C. Ley, J. Lankester, T. Hastie, and J. Parsonnet. 2020. Decreasing human body temperature in the United States since the industrial revolution. Elife 9:e49555.
Rao, V. U. S., G. Arakeri, G. Madikeri, A. Shah, R. S. Oeppen, and P. A. Brennan. 2021. COVID-19 associated mucormycosis (CAM) in India: A formidable challenge. British Journal of Oral Maxillofacial Surgery 59(9):1095-1098.
Rauseo, A. M., A. Coler-Reilly, L. Larson, and A. Spec. 2020. Hope on the horizon: Novel fungal treatments in development. Open Forum Infectious Diseases 7(2):ofaa016.
Ren, J., X. Jin, Q. Zhang, Y. Zheng, D. Lin, and Y. Yu. 2017. Fungicides induced triazole-resistance in Aspergillus fumigatus associated with mutations of TR46/Y121F/T289A and its appearance in agricultural fields. Journal of Hazardous Materials 326:54-60.
Resendiz-Sharpe, A., K. Dewaele, R. Merckx, B. Bustamante, M. C. Vega-Gomez, M. Rolon, J. Jacobs, P. E. Verweij, J. Maertens, and K. Lagrou. 2021. Triazole-resistance in environmental Aspergillus fumigatus in Latin American and African countries. Journal of Fungi (Basel) 7(4).
Rex, J., and Krause, K. 2021. All-in cost of a new antibiotic from discovery to 10 years on market. January 9. AMR Solutions. https://amr.solutions/2021/01/09/all-in-cost-of-a-new-antibiotic-from-discovery-to-10-years-on-market (accessed April 26, 2023).
Rhodes, J., and M. C. Fisher. 2019. Global epidemiology of emerging Candida auris. Current Opinions in Microbiology 52:84-89.
Rhodes, J., A. Abdolrasouli, K. Dunne, T. R. Sewell, Y. Zhang, E. Ballard, A. P. Brackin, N. van Rhijn, A. Tsitsopoulou, R. B. Posso, S. H. Chotirmall, N. G. McElvaney, P. G. Murphy, A. F. Talento, J. Renwick, P. S. Dyer, A. Szekely, M. J. Bromley, E. M. Johnson, P. L. White, A. Warris, R. C. Barton, S. Schelenz, T. R. Rogers, D. Armstrong-James, and M. C. Fisher. 2021. Tracing patterns of evolution and acquisition of drug resistant Aspergillus fumigatus infection from the environment using population genomics. bioRxiv:2021.2004.2007.438821.
Rhodes, J., A. Abdolrasouli, K. Dunne, T. R. Sewell, Y. Zhang, E. Ballard, A. P. Brackin, N. van Rhijn, H. Chown, A. Tsitsopoulou, R. B. Posso, S. H. Chotirmall, N. G. McElvaney, P. G. Murphy, A. F. Talento, J. Renwick, P. S. Dyer, A. Szekely, P. Bowyer, M. J. Bromley, E. M. Johnson, P. Lewis White, A. Warris, R. C. Barton, S. Schelenz, T. R. Rogers, D. Armstrong-James, and M. C. Fisher. 2022. Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nature Microbiology 7(5):663-674.
Richtel, M., and A. Jacobs. 2019. Fungus immune to drugs quietly sweeps the globe. The New York Times, April 7.
Robert, V. A., and A. Casadevall. 2009. Vertebrate endothermy restricts most fungi as potential pathogens. J Infect Dis 200(10):1623-1626.
Rocchi, S., E. Daguindau, F. Grenouillet, E. Deconinck, A.-P. Bellanger, D. Garcia-Hermoso, S. Bretagne, G. Reboux, and L. Millon. 2014. Azole-resistant Aspergillus fumigatus isolate with the TR34/L98H mutation in both a fungicide-sprayed field and the lung of a hematopoietic stem cell transplant recipient with invasive aspergillosis. Journal of Clinical Microbiology 52(5):1724-1726.
Roschewski, M., M. S. Lionakis, C. Melani, J. A. Butman, S. Pittaluga, A. N. Lucas, S. M. Steinberg, E. S. Jaffe, R. F. Little, L. M. Staudt, and W. H. Wilson. 2018. Dose-adjusted TEDDI-R induces durable complete remissions in relapsed and refractory primary CNS lymphoma. Blood 132(Supplement 1):4195-4195.
Rutjanawech, S., C. Mejia-Chew, C. Ayres, and A. Spec. 2021. A canker barking at the wrong knee: Thyronectria austroamericana septic arthritis. Open Forum Infectious Diseases 8(8):ofab381.
Satapute, P., and B. Kaliwal. 2016. Biodegradation of the fungicide propiconazole by Pseudomonas aeruginosa PS-4 strain isolated from a paddy soil. Annals of Microbiology 66(4):1355-1365.
Savary, S., L. Willocquet, S. J. Pethybridge, P. Esker, N. McRoberts, and A. Nelson. 2019. The global burden of pathogens and pests on major food crops. Nature Ecology & Evolution 3(3):430-439.
Schnabel, G., and D. R. Layne. 2004. Comparison of reduced-application and sulfur-based fungicide programs on scab intensity, fruit quality, and cost of disease control on peach. Plant Diseases 88(2):162-166.
Schoustra, S., J. Zhang, B. Zwaan, A. Debets, P. Verweij, D. Buijtenhuijs, and A. Rietveld. 2019a. New insights in the development of azole-resistance in Aspergillus fumigatus. The Netherlands: National Institute for Public Health and the Environment.
Schoustra, S. E., A. J. M. Debets, A. Rijs, J. Zhang, E. Snelders, P. C. Leendertse, W. J. G. Melchers, A. G. Rietveld, B. J. Zwaan, and P. E. Verweij. 2019b. Environmental hotspots for azole resistance selection of Aspergillus fumigatus, the Netherlands. Emerging Infectious Diseases 25(7):1347-1353.
Shelton, J. M. G. 2021. Environmental drivers of azole-resistance in Aspergillus fumigatus and its relevance to human health (dissertation). London, UK: Imperial College London.
Shelton, J. M. G., M. C. Fisher, and A. C. Singer. 2020. Campaign-based citizen science for environmental mycology: The science solstice and summer soil-stice projects to assess drug resistance in air- and soil-borne Aspergillus fumigatus. Citizen Science: Theory and Practice 5(1):20.
Shelton, J. M. G., R. Collins, C. B. Uzzell, A. Alghamdi, P. S. Dyer, A. C. Singer, and M. C. Fisher. 2022. Citizen science surveillance of triazole-resistant Aspergillus fumigatus in United Kingdom residential garden soils. Applied and Environmental Microbiology 88(4):e0206121.
Singla, R., R. Singhal, R. Rathore, A. Gupta, P. Sethi, V. P. Myneedu, A. Chakraborty, and V. Kumar. 2021. Risk factors for chronic pulmonary aspergillosis in post-TB patients. International Journal of Tuberculosis and Lung Disease 25(4):324-326.
Smeekens, S. P., A. Ng, V. Kumar, M. D. Johnson, T. S. Plantinga, C. van Diemen, P. Arts, E. T. Verwiel, M. S. Gresnigt, K. Fransen, S. van Sommeren, M. Oosting, S. C. Cheng, L. A. Joosten, A. Hoischen, B. J. Kullberg, W. K. Scott, J. R. Perfect, J. W. van der Meer, C. Wijmenga, M. G. Netea, and R. J. Xavier. 2013. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nature Communications 4:1342.
Smothers, H. 2016. A deadly, drug-resistant yeast infection is spreading around the world, it’s fine guys. Cosmopolitan. June 30. https://www.cosmopolitan.com/sex-love/news/a60773/yeast-infection-drug-resistant-fatal (accessed April 26, 2023).
Snelders, E., H. A. van der Lee, J. Kuijpers, A. J. Rijs, J. Varga, R. A. Samson, E. Mellado, A. R. Donders, W. J. Melchers, and P. E. Verweij. 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Medicine 5(11):e219.
Snelders, E., W. J. Melchers, and P. E. Verweij. 2011. Azole resistance in Aspergillus fumigatus: A new challenge in the management of invasive aspergillosis? Future Microbiology 6(3):335-347.
Snelders, E., S. M. Camps, A. Karawajczyk, G. Schaftenaar, G. H. Kema, H. A. van der Lee, C. H. Klaassen, W. J. Melchers, and P. E. Verweij. 2012. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One 7(3):e31801.
Song, Y., J. B. Buil, W. J. G. Melchers, J. Zoll, and P. E. Verweij. 2022. P001 characteristics and dynamics of azole-resistant Aspergillus fumigatus variants emerging over a 28-year period in the Netherlands. Medical Mycology 60(Supplement_1).
Southwick, K., E. H. Adams, J. Greenko, B. Ostrowsky, R. Fernandez, R. Patel, M. Quinn, S. Vallabhaneni, R. J. Denis, R. Erazo, S. Chaturvedi, V. B. Haley, L. Leach, Y. C. Zhu, R. Giardina, E. C. Lutterloh, and D. S. Blog. 2018. New York State 2016–2018: Progression from Candida auris colonization to bloodstream infection. Open Forum Infectious Diseases 5(suppl_1):S594-S595.
Souza, A. C., B. B. Fuchs, H. M. Pinhati, R. A. Siqueira, F. Hagen, J. F. Meis, E. Mylonakis, and A. L. Colombo. 2015. Candida parapsilosis resistance to fluconazole: Molecular mechanisms and in vivo impact in infected Galleria mellonella larvae. Antimicrobial Agents and Chemotherapy 59(10):6581-6587.
Spec, A., G. Escota, C. Chrisler, and B. Davies. 2019. Comprehensive review of infectious diseases. Cambridge, MA: Elsevier.
Steffen, W., W. Broadgate, L. Deutsch, O. Gaffney, and C. Ludwig. 2015. The trajectory of the anthropocene: The great acceleration. The Anthropocene Review 2(1):81-98.
Stevens, D. 2011. Systemic antifungal agents. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 7 ed., edited by G. Mandell, J. Bennett and R. Dolin. Philadelphia, PA: Churchill Livingstone. Pp. 549-563.
Sucher, A. J., E. B. Chahine, and H. E. Balcer. 2009. Echinocandins: The newest class of antifungals. Annals of Pharmacotherapy 43(10):1647-1657.
Swamydas, M., J. L. Gao, T. J. Break, M. D. Johnson, M. Jaeger, C. A. Rodriguez, J. K. Lim, N. M. Green, A. L. Collar, B. G. Fischer, C. C. Lee, J. R. Perfect, B. D. Alexander, B. J. Kullberg, M. G. Netea, P. M. Murphy, and M. S. Lionakis. 2016. CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival. Science Translational Medicine 8(322):322ra310.
Tenforde, M. W., A. M. Gertz, D. S. Lawrence, N. K. Wills, B. L. Guthrie, C. Farquhar, and J. N. Jarvis. 2020. Mortality from HIV-associated meningitis in sub-Saharan Africa: A systematic review and meta-analysis. Journal of the International AIDS Society 23(1):e25416-e25416.
Thiessen, L. D., J. A. Keune, T. M. Neill, W. W. Turechek, G. G. Grove, and W. F. Mahaffee. 2016. Development of a grower-conducted inoculum detection assay for management of grape powdery mildew. Plant Pathology 65(2):238-249.
Thiessen, L. D., T. M. Neill, and W. F. Mahaffee. 2017. Timing fungicide application intervals based on airborne Erysiphe necator concentrations. Plant Disease 101(7):1246-1252.
Thiessen, L. D., T. M. Neill, and W. F. Mahaffee. 2018. Development of a quantitative loop-mediated isothermal amplification assay for the field detection of Erysiphe necator. PeerJ 6:e4639.
Toda, M., S. R. Williams, E. L. Berkow, M. M. Farley, L. H. Harrison, L. Bonner, K. M. Marceaux, R. Hollick, A. Y. Zhang, W. Schaffner, S. R. Lockhart, B. R. Jackson, and S Vallabhaneni. 2019. Population-based active surveillance for culture-confirmed candidemia—Four sites, United States, 2012-2016. MMWR Surveillance Summaries 68(8):1-15. http://dx.doi.org/10.15585/mmwr.ss6808a1.
Toda, M., K. D. Beer, K. M. Kuivila, T. M. Chiller, and B. R. Jackson. 2021. Trends in agricultural triazole fungicide use in the United States, 1992-2016 and possible implications for antifungal-resistant fungi in human disease. Environmental Health Perspectives 129(5):55001.
Trevino-Rangel, R. J., H. Villanueva-Lozano, A. Bonifaz, L. R. Castanon-Olivares, A. Andrade, M. A. Becerril-Garcia, M. F. Martinez-Resendez, J. Ayala-Gaytan, A. M. Montoya, and G. M. Gonzalez. 2021. Species distribution and antifungal susceptibility patterns of Aspergillus isolates from clinical specimens and soil samples in Mexico. Medical Mycology 59(10):1006-1014.
Ullmann, A. J., J. M. Aguado, S. Arikan-Akdagli, D. W. Denning, A. H. Groll, K. Lagrou, C. Lass-Flörl, R. E. Lewis, P. Munoz, P. E. Verweij, A. Warris, F. Ader, M. Akova, M. C. Arendrup, R. A. Barnes, C. Beigelman-Aubry, S. Blot, E. Bouza, R. J. M. Brüggemann, D. Buchheidt, J. Cadranel, E. Castagnola, A. Chakrabarti, M. Cuenca-Estrella, G. Dimopoulos, J. Fortun, J. P. Gangneux, J. Garbino, W. J. Heinz, R. Herbrecht, C. P. Heussel, C. C. Kibbler, N. Klimko, B. J. Kullberg, C. Lange, T. Lehrnbecher, J. Löffler, O. Lortholary, J. Maertens, O. Marchetti, J. F. Meis, L. Pagano, P. Ribaud, M. Richardson, E. Roilides, M. Ruhnke, M. Sanguinetti, D. C. Sheppard, J. Sinkó, A. Skiada, M. J. G. T. Vehreschild, C. Viscoli, and O. A. Cornely. 2018. Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical Microbiology and Infection 24:e1-e38.
van den Bosch, F., F. Lopez-Ruiz, R. Oliver, N. Paveley, J. Helps, and F. van den Berg. 2018. Identifying when it is financially beneficial to increase or decrease fungicide dose as resistance develops. Plant Pathology 67(3):549-560.
van der Linden, J. W., S. M. Camps, G. A. Kampinga, J. P. Arends, Y. J. Debets-Ossenkopp, P. J. Haas, B. J. Rijnders, E. J. Kuijper, F. H. van Tiel, J. Varga, A. Karawajczyk, J. Zoll, W. J. Melchers, and P. E. Verweij. 2013. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clinical Infectious Diseases 57(4):513-520.
Van Der Linden, J. W., A. Warris, and P. E. Verweij. 2011. Aspergillus species intrinsically resistant to antifungal agents. Medical Mycology 49(Suppl 1):S82-S89.
van der Wurff, A. W., J. Fuchs, M. Raviv, and A. Termorshuizen. 2016. Handbook for composting and compost use in organic horticulture. BioGreenhouse.
Vergidis, P., C. B. Moore, L. Novak-Frazer, R. Rautemaa-Richardson, A. Walker, D. W. Denning, and M. D. Richardson. 2020. High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum. Clinical Microbiology and Infection 26(7):935-940.
Verweij, P. E., E. Mellado, and W. J. Melchers. 2007. Multiple-triazole-resistant aspergillosis. New England Journal of Medicine 356(14):1481-1483.
Verweij, P. E., E. Snelders, G. H. Kema, E. Mellado, and W. J. Melchers. 2009. Azole resistance in Aspergillus fumigatus: A side-effect of environmental fungicide use? Lancet Infectious Diseases 9(12):789-795.
Verweij, P. E., M. Ananda-Rajah, D. Andes, M. C. Arendrup, R. J. Bruggemann, A. Chowdhary, O. A. Cornely, D. W. Denning, A. H. Groll, K. Izumikawa, B. J. Kullberg, K. Lagrou, J. Maertens, J. F. Meis, P. Newton, I. Page, S. Seyedmousavi, D. C. Sheppard, C. Viscoli, A. Warris, and J. P. Donnelly. 2015. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resistance Updates 21-22:30-40.
Verweij, P. E., A. Chowdhary, W. J. Melchers, and J. F. Meis. 2016. Azole resistance in Aspergillus fumigatus: Can we retain the clinical use of mold-active antifungal azoles? Clinical Infectious Diseases 62(3):362-368.
Viegas, C., T. Faria, L. A. Caetano, E. Carolino, A. Q. Gomes, and S. Viegas. 2017. Aspergillus spp. Prevalence in different Portuguese occupational environments: What is the real scenario in high load settings? Journal of Occupational and Environmental Hygiene 14(10):771-785.
Viegas, C., B. Almeida, L. Aranha Caetano, A. Afanou, A. Straumfors, C. Verissimo, P. Goncalves, and R. Sabino. 2022. Algorithm to assess the presence of Aspergillus fumigatus resistant strains: The case of Norwegian sawmills. International Journal of Environmental Research 32(5):963-971.
Warrilow, A. G., C. M. Hull, J. E. Parker, E. P. Garvey, W. J. Hoekstra, W. R. Moore, R. J. Schotzinger, D. E. Kelly, and S. L. Kelly. 2014. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme. Antimicrobial Agents and Chemotherapy 58(12):7121-7127.
Weiner-Lastinger, L. M., K. Haass, C. Gross, D. Leaptrot, E. Wong, H. Wu, and M. A. Dudeck. 2022. Pathogens attributed to central line-associated bloodstream infections in US acute care hospitals during the first year of the COVID-19 pandemic. Infection Control and Hospital Epidemiology Feb 8:1-13.
WHO (World Health Organization). 2017. Integrated surveillance of antimicrobial resistance in foodborne bacteria: Application of a One Health approach. Geneva: World Health Organization.
WHO. 2018. Mycotoxins. https://www.who.int/news-room/fact-sheets/detail/mycotoxins (accessed August 31, 2022).
WHO. 2019. No time to wait: Securing the future from drug-resistant infections. https://www.who.int/publications/i/item/no-time-to-wait-securing-the-future-from-drug-resistant-infections (accessed February 17, 2023).
WHO. 2020. First meeting of the WHO Antifungal Expert Group on Identifying Priority Fungal Pathogens: Meeting report. Geneva: World Health Organization.
WHO. 2021. Antimicrobial resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance (accessed August 31, 2022).
WHO, FAO, and OIE (World Organisation for Animal Health). 2019. Monitoring and evaluation of the global action plan on antimicrobial resistance: Framework and recommended indicators. Geneva: World Health Organization.
WHO, FAO, OIE, and UNEP (United Nations Environment Programme). 2022a. Antimicrobial resistance multi-partner trust fund annual report 2021. Geneva: WHO, FAO, OIE, UNEP.
WHO, FAO, OIE, and UNEP. 2022b. Strategic framework for collaboration on antimicrobial resistance—together for One Health. Geneva: World Health Organization, Food and Agriculture Organization of the United Nations and World Organisation for Animal Health.
Wiederhold, N. P., V. G. Gil, F. Gutierrez, J. R. Lindner, M. T. Albataineh, D. I. McCarthy, C. Sanders, H. Fan, A. W. Fothergill, and D. A. Sutton. 2016. First detection of TR34 L98H and TR46 Y121F T289A cyp51 mutations in Aspergillus fumigatus isolates in the United States. Journal of Clinical Microbiology 54(1):168-171.
Wiederhold, N. P., and P. E. Verweij. 2020. Aspergillus fumigatus and pan-azole resistance: Who should be concerned? Current Opinion in Infectious Diseases 33(4):290-297.
Wiegand, S., R. Berner, A. Schneider, E. Lundershausen, and A. Dietz. 2019. Otitis externa: Investigation and evidence-based treatment. Deutsches Ärzteblatt International 116: 224–234.
Winters, B., J. Custer, S. M. Galvagno, Jr., E. Colantuoni, S. G. Kapoor, H. Lee, V. Goode, K. Robinson, A. Nakhasi, P. Pronovost, and D. Newman-Toker. 2012. Diagnostic errors in the intensive care unit: A systematic review of autopsy studies. BMJ Quality & Safety 21(11):894-902.
Wouters, O. J., M. McKee, and J. Luyten. 2020. Estimated research and development investment needed to bring a new medicine to market, 2009-2018. JAMA 323(9):844-853.
Wu, P., T. E. Nielsen, and M. H. Clausen. 2016. Small-molecule kinase inhibitors: An analysis of FDA-approved drugs. Drug Discovery Today 21(1):5-10.
Xing, Y., J. F. Hernandez Nopsa, K. F. Andersen, J. L. Andrade-Piedra, F. D. Beed, G. Blomme, M. Carvajal-Yepes, D. L. Coyne, W. J. Cuellar, G. A. Forbes, J. F. Kreuze, J. Kroschel, P. L. Kumar, J. P. Legg, M. Parker, E. Schulte-Geldermann, K. Sharma, and K. A. Garrett. 2020. Global cropland connectivity: A risk factor for invasion and saturation by emerging pathogens and pests. Bioscience 70(9):744-758.
Xu, H., L. Li, W. J. Huang, L. X. Wang, W. F. Li, and W. F. Yuan. 2012. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: A case control study from China. Clinical Microbiology and Infection 18(4):403-408.
Zarakas, M. A., J. V. Desai, G. Chamilos, and M. S. Lionakis. 2019. Fungal infections with ibrutinib and other small-molecule kinase inhibitors. Curr Fungal Infect Rep 13(3):86-98.
Zhang, J., A. J. Debets, P. E. Verweij, W. J. Melchers, B. J. Zwaan, and S. E. Schoustra. 2015. Asexual sporulation facilitates adaptation: The emergence of azole resistance in Aspergillus fumigatus. Evolution 69(10):2573-2586.
Zhang, J., E. Snelders, B. J. Zwaan, S. E. Schoustra, J. F. Meis, K. van Dijk, F. Hagen, M. T. van der Beek, G. A. Kampinga, J. Zoll, W. J. G. Melchers, P. E. Verweij, and A. J. M. Debets. 2017a. A novel environmental azole resistance mutation in Aspergillus fumigatus and a possible role of sexual reproduction in its emergence. mBio 8(3).
Zhang, J., J. van den Heuvel, A. J. M. Debets, P. E. Verweij, W. J. G. Melchers, B. J. Zwaan, and S. E. Schoustra. 2017b. Evolution of cross-resistance to medical triazoles in Aspergillus fumigatus through selection pressure of environmental fungicides. Proceedings of the Royal Society B: Biological Sciences 284(1863).
Zhang, J., A. J. M. Debets, P. E. Verweij, and S. E. Schoustra. 2021a. Selective flamingo medium for the isolation of Aspergillus fumigatus. Microorganisms 9(6).
Zhang, J., A. J. M. Debets, P. E. Verweij, and E. Snelders. 2021b. Azole-resistance development; how the Aspergillus fumigatus lifecycle defines the potential for adaptation. Journal of Fungi (Basel) 7(8).
Zhang, J., L. Lopez Jimenez, E. Snelders, A. J. M. Debets, A. G. Rietveld, B. J. Zwaan, P. E. Verweij, and S. E. Schoustra. 2021c. Dynamics of Aspergillus fumigatus in azole fungicide-containing plant waste in the Netherlands (2016-2017). Applied and Environmental Microbiology 87(2):e02295-02220.
Zhang, J., P. E. Verweij, A. Rijs, A. J. M. Debets, and E. Snelders. 2021d. Flower bulb waste material is a natural niche for the sexual cycle in Aspergillus fumigatus. Frontiers in Cellular and Infection Microbiology 11:785157.
Zhou, D., G. A. Korfanty, M. Mo, R. Wang, X. Li, H. Li, S. Li, J. Y. Wu, K. Q. Zhang, Y. Zhang, and J. Xu. 2021. Extensive genetic diversity and widespread azole resistance in greenhouse populations of Aspergillus fumigatus in Yunnan, China. mSphere 6(1).
This page intentionally left blank.
